Hypogonadism in male patients with cancer
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients with cancer often develop anorexia, fatigue, and decreased muscle mass. These signs and symptoms are nonspecific, and they frequently occur in other conditions, including hypogonadism. METHODS: The objectives of this study were 1) to measure testosterone levels in patients with cancer and 2) to examine the correlations between testosterone, tumor necrosis factor‐α (TNF‐α), interleukin‐6 (IL‐6), insulin‐like growth factor‐1 (IGF‐1), ghrelin levels, and appetite in patients with cancer patients and in a noncancer control group. This was designed as a cross‐sectional study in the setting of a university‐affiliated Veterans Affairs Medical Center. The study population included 31 male patients with cancer and 25 gender‐matched noncancer controls of similar age. The variables total testosterone (TT), calculated free testosterone (cFT), calculated bioavailable testosterone (cBT), sex hormone‐binding globulin (SHBG), luteinizing hormone (LH), TNF‐α, IL‐6, IGF‐1, and active ghrelin were measured in fasting morning plasma samples. Appetite was measured according to a visual analog scale. The main outcome measures were cFT and cBT. RESULTS: Cancer patients had mean TT levels similar to levels in the noncancer control group but significantly lower levels of cFT, cBT, IGF‐1, and appetite. SHBG, LH, TNF‐α, IL‐6, and ghrelin levels were increased in patients with cancer compared with the control group. cFT and cBT levels were correlated inversely with IL‐6 and ghrelin levels and were correlated directly with IGF‐1 levels and appetite. CONCLUSIONS: Patients with cancer had lower levels of biologically active testosterone. TT was not adequate for the evaluation of hypogonadism, because SHBG levels were increased. A reliable measurement of FT and/or BT should be used. LH was elevated in the patients with cancer, indicating that low FT levels were caused by primary testicular dysfunction. The authors postulated that high IL‐6 or ghrelin levels inhibit testosterone synthesis, although a secondary effect at the hypothalamic‐pituitary levels cannot be excluded. Cancer 2006. © 2006 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · cited 1×
“Calculated FT (cFT) and calculated BT (cBT) values have been shown to correlate well with those obtained by the most reliable methods of FT and BT measurements, such as ammonium sulfate precipitation.(31) We confirmed that our results were equivalent to those calculated by the equation of Vermeulen et al.”
ResultGhrelin enhances appetite and increases food intake in humans
Wren, A. M., Seal, L. J., Cohen, M. A., Brynes, A. E., Frost, G. S., Murphy, K. G., Dhillo, W. S., Ghatei, M. A., & Bloom, S. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8111 · Cited by 2,494 · cited 1×
“Ghrelin, a 28-amino-acid peptide that is secreted mainly from the stomach,(20,21) is a potent GH-secretagogue(22) that increases food intake and body weight in both animals and humans.(23) Patients with cancerinduced cachexia have increased plasma levels of ghrelin.”
BackgroundSödergard, R., Bäckström, T., Shanbhag, V., & Carstensen, H. (1982) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(82)90038-3 · Cited by 1,080
Ghrelin Strongly Stimulates Growth Hormone Release in Humans
Takaya, K., Ariyasu, H., Kanamoto, N., Iwakura, H., Yoshimoto, A., Harada, M., Mori, K., Komatsu, Y., Usui, T., Shimatsu, A., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7167 · Cited by 864
Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis
Urban, R. J., Bodenburg, Y. H., Gilkison, C., Foxworth, J., Coggan, A. R., Wolfe, R. R., & Ferrando, A. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.269.5.e820 · Cited by 608
Ferrando, A. A., Sheffield-Moore, M., Yeckel, C. W., Gilkison, C., Jiang, J., Achacosa, A., Lieberman, S. A., Tipton, K., Wolfe, R. R., & Urban, R. J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00362.2001 · Cited by 522
Endocrine consequences of long-term intrathecal administration of opioids
Abs, R., Verhelst, J., Maeyaert, J., Van Buyten, J.-P., Opsomer, F., Adriaensen, H., Verlooy, J., Van Havenbergh, T., Smet, M., & Van Acker, K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.6.6615 · Cited by 491
Diver, M. J., Imtiaz, K. E., Ahmad, A. M., Vora, J. P., & Fraser, W. D. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01772.x · Cited by 338
Miller, K. K., Rosner, W., Lee, H., Hier, J., Sesmilo, G., Schoenfeld, D., Neubauer, G., & Klibanski, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030680 · Cited by 301
Svartberg, J., Midtby, M., Bonaa, K., Sundsfjord, J., Joakimsen, R., & Jorde, R. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490145 · Cited by 257
Cited by
Lenk, K., Schuler, G., & Adams, V. (2010) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-010-0007-1 · Cited by 494
Cancer cachexia—pathophysiology and management
Suzuki, H., Asakawa, A., Amitani, H., Nakamura, N., & Inui, A. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0787-0 · Cited by 268
Systematic review of the association between circulating interleukin-6 (IL-6) and cancer
Heikkilä, K., Ebrahim, S., & Lawlor, D. A. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.02.047 · Cited by 232
Roles of ghrelin and leptin in the control of reproductive function
Tena-Sempere, M. (2007) · Neuroendocrinology · doi:10.1159/000108410 · Cited by 141
“Such concurrent actions might be mechanistically relevant to define the spectrum of reproductive disturbances linked to alterations in energy balance, such as defective testosterone secretion not only in conditions of energy insufficiency, where excess of ghrelin has been proposed as causative factor [”
BackgroundStrasser, F., Palmer, J. L., Schover, L. R., Yusuf, S. W., Pisters, K., Vassilopoulou‐Sellin, R., DeGracia, B., Willey, J. S., & Bruera, E. (2006) · Cancer · doi:10.1002/cncr.22339 · Cited by 112
“sion of testosterone levels without changes in gonadotrophins, and increased SHBG.(28,29) The finding of a strong association between hypogonadism and negative mood, as documented by the HADS-A, HADS-D, and FACT Emotional Well-Being subscale, is consistent with the reported impact of hypogonadism on mood in elderly me…”
BackgroundResult
Metadata
- Authors
- Garcia, J. M., Li, H., Mann, D., Epner, D., Hayes, T. G., Marcelli, M., & Cunningham, G. R.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2006-05-10
- Volume
- 106
- Issue
- 12
- Pages
- 2583-2591
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2047522222
- Cited by
- 100
- References
- 16
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypogonadism in male patients with cancer. https://app.cochat.ai/papers/10.1002/cncr.21889
- The paper
- Garcia, J. M., Li, H., Mann, D., Epner, D., Hayes, T. G., Marcelli, M., & Cunningham, G. R. (2006). Hypogonadism in male patients with cancer. Cancer. https://doi.org/10.1002/cncr.21889
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.